Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
4,715 results
- Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05325944).
- DIGITS PilotIndependent statistical analysis of An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02981082).
- DIODEIndependent statistical analysis of De-Implementing Opioids for Dental Extractions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03584789).
- DIPIndependent statistical analysis of Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Discrete Versus Rhythmic Gait Training: Complete Statistical AnalysisIndependent statistical analysis of Discrete Versus Rhythmic Gait Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02650440).
- Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation: Complete Statistical AnalysisIndependent statistical analysis of Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02010151).
- Dispensing Evaluation of Investigational Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Dispensing Evaluation of Investigational Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02625220).
- Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02065453).
- Disposable Powered Articulating Linear Cutter Stapler in Total-Thoracoscopic Anatomic Lobectomy (Segmentectomy): Complete Statistical AnalysisIndependent statistical analysis of Disposable Powered Articulating Linear Cutter Stapler in Total-Thoracoscopic Anatomic Lobectomy (Segmentectomy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DISSOLVE IIndependent statistical analysis of A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DIVERTIndependent statistical analysis of Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DKP 3M SCIndependent statistical analysis of Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DOAC LVADIndependent statistical analysis of Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DOANIndependent statistical analysis of Cognitive and Emotional Skills to Aid Smoking Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03058991).
- DOC-MEKIndependent statistical analysis of Docetaxel With or Without AZD6244 in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01256359).
- Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01382706).
- Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?: Complete Statistical AnalysisIndependent statistical analysis of Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene: Complete Statistical AnalysisIndependent statistical analysis of Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults: primary endpoint results, effect estimate with confidence…
- Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases: Complete Statistical AnalysisIndependent statistical analysis of Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- DOPAACRO 002Independent statistical analysis of Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DORAVIPEPIndependent statistical analysis of Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study: primary endpoint results, effect…
- Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): Complete Statistical AnalysisIndependent statistical analysis of Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01976741).
- Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID): Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID): primary endpoint results, effect…
- Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dose Optimization Trial of CD19 Redirected Autologous T Cells: Complete Statistical AnalysisIndependent statistical analysis of Dose Optimization Trial of CD19 Redirected Autologous T Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747486).
- Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): primary endpoint results,…
- Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: primary endpoint results, effect estimate with…